Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition.
Saved in:
| Title: | Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition. |
|---|---|
| Authors: | Lindsay C; Department of Pharmacology, University of Oxford, Oxford, UK., Musgaard M; Structural Bioinformatics and Computational Biochemistry, Department of Biochemistry, University of Oxford, Oxford, UK.; OMass Therapeutics, Oxford, UK., Russell AJ; Department of Pharmacology, University of Oxford, Oxford, UK.; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK., Sitsapesan R; Department of Pharmacology, University of Oxford, Oxford, UK. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2022 Nov; Vol. 179 (21), pp. 4941-4957. Date of Electronic Publication: 2022 Aug 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35703154 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lindsay+C%22">Lindsay C</searchLink>; Department of Pharmacology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Musgaard+M%22">Musgaard M</searchLink>; Structural Bioinformatics and Computational Biochemistry, Department of Biochemistry, University of Oxford, Oxford, UK.; OMass Therapeutics, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Russell+AJ%22">Russell AJ</searchLink>; Department of Pharmacology, University of Oxford, Oxford, UK.; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Sitsapesan+R%22">Sitsapesan R</searchLink>; Department of Pharmacology, University of Oxford, Oxford, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227502536%22">British journal of pharmacology</searchLink> [Br J Pharmacol] 2022 Nov; Vol. 179 (21), pp. 4941-4957. <i>Date of Electronic Publication: </i>2022 Aug 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7502536 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5381 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071188%22">00071188 </searchLink><i>NLM ISO Abbreviation: </i>Br J Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35703154 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bph.15893 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4941 Titles: – TitleFull: Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lindsay C – PersonEntity: Name: NameFull: Musgaard M – PersonEntity: Name: NameFull: Russell AJ – PersonEntity: Name: NameFull: Sitsapesan R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2022 Nov Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1476-5381 Numbering: – Type: volume Value: 179 – Type: issue Value: 21 Titles: – TitleFull: British journal of pharmacology Type: main |
| ResultId | 1 |